Ana Campistrous-Lopez
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Neuroendocrine tumour morphology and platelet derived growth factor receptor alpha expression.
Journal: Experimental and molecular pathology
Published: June 16, 2025
First-Generation Radiolabeled Cyclic Peptides for Molecular Imaging of Platelet-Derived Growth Factor Receptor α.
Journal: Molecular pharmaceutics
Published: August 17, 2024
Apolipoprotein-A1 transports and regulates MMP2 in the blood.
Journal: Nature communications
Published: January 25, 2024
Tyrosine kinase inhibitor therapy and metabolic remodelling in papillary thyroid cancer.
Journal: Endocrine-related cancer
Published: June 18, 2020
Gene expression profile of epithelial-mesenchymal transition mediators in papillary thyroid cancer.
Journal: Endocrine
Published: November 29, 2019
Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET.
Journal: Nuclear medicine and biology
Published: July 17, 2017
Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.
Journal: Oncotarget
Published: June 30, 2016
PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer.
Journal: EBioMedicine
Published: June 16, 2016
Autotaxin is an inflammatory mediator and therapeutic target in thyroid cancer.
Journal: Endocrine-related cancer
Published: June 02, 2015
Proteomic analysis of brain mitochondrial proteome and mitochondrial complexes.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 23, 2013
Last Updated: 09/26/2026